[莫西多明制剂对合并循环衰竭的缺血性心脏病患者冠状动脉及心肌储备的影响]
[The effect of molsidomine preparations on the coronary and myocardial reserves of patients with IHD complicated by circulatory failure].
作者信息
Ol'binskaia L I, Sizova Zh M, Alekperov E E
出版信息
Ter Arkh. 1994;66(8):30-2.
PMID:7985149
Abstract
Molsidomine drugs corvaton and sidnopharm were given as monotherapy to 95 coronary heart disease (CHD) patients with circulatory defects. Positive effects on coronary and myocardial reserves were reported in 70,8 and 58.3%, 68,4 and 56.8% of cases, respectively. Corvaton caused side effects in 3.1%, sidnopharm in 12.5% of the patients. Corvaton is more potent as regards hemodynamics, myocardial contractility and reserves.
摘要
莫西多明药物可伐汀和西多芬被作为单一疗法给予95名患有循环系统缺陷的冠心病（CHD）患者。据报告，分别在70.8%和58.3%、68.4%和56.8%的病例中，对冠状动脉和心肌储备有积极作用。可伐汀在3.1%的患者中引起副作用，西多芬在12.5%的患者中引起副作用。在血流动力学、心肌收缩力和储备方面，可伐汀的效力更强。
Zotero 插件